Revolution Medicines, Inc.
RVMD
37 insider filings · Latest: Jun 29, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Jul 1 10:25 PM | Sushil PatelDirector | Sale | 5,580 | $187.99 | $1.0M | 21,656(D) | View → |
| Jun 29, 2026 | Jun 29 8:44 PM | SUSHIL PATEL | Proposed Sale | 5,580 | $182.08 | $1.0M | — | View → |
| Jun 24, 2026 | Jun 26 8:10 PM | Jack AndersChief Financial Officer | Sale | 20,000 | $168.33 | $3.4M | 123,269(D) | View → |
| Jun 24, 2026 | Jun 24 8:35 PM | JACK ANDERS | Proposed Sale | 20,000 | $169.51 | $3.4M | — | View → |
| Jun 16, 2026 | Jun 18 8:11 PM | Anthony ManciniChief Global Commercialization Officer | Sale | 4,615 | $156.12 | $720.5K | 49,975(D) | View → |
| Jun 16, 2026 | Jun 18 8:11 PM | Mark A GoldsmithDirector, President and Chief Executive Officer | Sale | 10,020 | $156.12 | $1.6M | 267,330(D) | View → |
| Jun 16, 2026 | Jun 18 8:10 PM | Jeff CisliniGeneral Counsel | Sale | 2,157 | $156.12 | $336.7K | 56,521(D) | View → |
| Jun 16, 2026 | Jun 18 8:10 PM | Jack AndersChief Financial Officer | Sale | 2,722 | $156.12 | $425.0K | 123,269(D) | View → |
| Jun 16, 2026 | Jun 18 8:10 PM | Stephen Michael KelseyPresident, Research and Development | Sale | 4,175 | $156.12 | $651.8K | 291,876(D) | View → |
| Jun 17, 2026 | Jun 17 11:51 PM | Margaret A HornChief Operating Officer | Sale | 29,600 | $160.12 | $4.7M | 154,647(D) | View → |
| Jun 15, 2026 | Jun 17 11:51 PM | Margaret A HornChief Operating Officer | Sale | 60,400 | $160.17 | $9.7M | 158,222(D) | View → |
| Jun 16, 2025 | Jun 17 11:51 PM | Margaret A HornChief Operating Officer | Sale | 3,575 | $156.12 | $558.1K | 154,647(D) | View → |
| Jun 15, 2026 | Jun 15 10:30 PM | GOLDSMITH MARK A | Proposed Sale | 9,772 | $153.87 | $1.5M | — | View → |
| Jun 15, 2026 | Jun 15 10:23 PM | Cislini Jeff | Proposed Sale | 1,656 | $153.87 | $254.8K | — | View → |
| Jun 15, 2026 | Jun 15 10:15 PM | Anders Jack | Proposed Sale | 2,653 | $153.87 | $408.2K | — | View → |
| Jun 15, 2026 | Jun 15 10:07 PM | Mancini Anthony | Proposed Sale | 4,211 | $153.87 | $647.9K | — | View → |
| Jun 15, 2026 | Jun 15 9:59 PM | Kelsey Stephen Michael | Proposed Sale | 4,071 | $153.87 | $626.4K | — | View → |
| Jun 15, 2026 | Jun 15 9:51 PM | Horn Margaret A | Proposed Sale | 3,486 | $153.87 | $536.4K | — | View → |
| Jun 15, 2026 | Jun 15 8:59 PM | MARGARET A HORN | Proposed Sale | 90,000 | $153.87 | $13.8M | — | View → |
| Jun 11, 2026 | Jun 15 8:05 PM | Margaret A HornChief Operating Officer | Sale | 10,000 | $148.01 | $1.5M | 158,222(D) | View → |
Page 1 of 6
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Jul 1 10:25 PM | Sushil PatelDirector | Option Exercise | 2,955 | $37.54 | 13,000(D) | View → |
| Jun 24, 2026 | Jun 26 8:10 PM | Jack AndersChief Financial Officer | Option Exercise | 20,000 | $18.56 | 20,600(D) | View → |
| Jun 18, 2026 | Jun 23 9:57 PM | Lorence H. KimDirector | Grant/Award | 3,127 | $162.99 | 3,127(D) | View → |
| Jun 18, 2026 | Jun 23 9:52 PM | Alexis BorisyDirector | Grant/Award | 3,127 | $162.99 | 3,127(D) | View → |
| Jun 18, 2026 | Jun 23 9:45 PM | Elizabeth M AndersonDirector | Grant/Award | 3,127 | $162.99 | 3,127(D) | View → |
| Jun 18, 2026 | Jun 23 9:45 PM | Sandra HorningDirector | Grant/Award | 3,127 | $162.99 | 3,127(D) | View → |
| Jun 18, 2026 | Jun 23 9:44 PM | Frank ClyburnDirector | Grant/Award | 3,127 | $162.99 | 3,127(D) | View → |
| Jun 18, 2026 | Jun 23 9:43 PM | Sushil PatelDirector | Grant/Award | 3,127 | $162.99 | 3,127(D) | View → |
| Jun 18, 2026 | Jun 23 9:42 PM | Flavia BorelliniDirector | Grant/Award | 3,127 | $162.99 | 3,127(D) | View → |
| Jun 17, 2026 | Jun 17 11:51 PM | Margaret A HornChief Operating Officer | Option Exercise | 29,600 | $40.74 | 114,275(D) | View → |
| Jun 15, 2026 | Jun 17 11:51 PM | Margaret A HornChief Operating Officer | Option Exercise | 60,400 | $40.74 | 75,052(D) | View → |
| Jun 11, 2026 | Jun 15 8:05 PM | Margaret A HornChief Operating Officer | Option Exercise | 10,000 | $42.45 | 91,194(D) | View → |
| May 26, 2026 | May 28 8:10 PM | Anthony ManciniChief Global Commercialization Officer | Option Exercise | 3,121 | $33.62 | 106,109(D) | View → |
| Apr 27, 2026 | Apr 29 9:50 PM | Anthony ManciniChief Global Commercialization Officer | Option Exercise | 3,120 | $33.62 | 109,230(D) | View → |
| Apr 15, 2026 | Apr 17 11:26 PM | Mark A GoldsmithDirector, President and Chief Executive Officer | Option Exercise | 120,000 | $4.73 | 424,085(D) | View → |
| Mar 25, 2026 | Mar 27 12:04 AM | Anthony ManciniChief Global Commercialization Officer | Option Exercise | 37,450 | $33.62 | 112,350(D) | View → |
| Mar 1, 2026 | Mar 4 2:11 AM | Xiaolin WangEVP, Clinical Development | Grant/Award | 34,000 | $102.02 | 34,000(D) | View → |
| Mar 1, 2026 | Mar 4 2:10 AM | Lin WeiChief Medical Officer | Grant/Award | 34,000 | $102.02 | 34,000(D) | View → |
| Mar 1, 2026 | Mar 4 2:09 AM | Stephen Michael KelseyPresident, Research and Development | Grant/Award | 47,600 | $102.02 | 47,600(D) | View → |
| Mar 2, 2026 | Mar 4 2:09 AM | Mark A GoldsmithDirector, President and Chief Executive Officer | Option Exercise | 30,000 | $4.09 | 47,708(D) | View → |
Page 1 of 2
Next →